Cerity Partners LLC Teva Pharmaceutical Industries LTD Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cerity Partners LLC holds 41,401 shares of TEVA stock, worth $864,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,401

Previous 43,762 5.4%

Holding current value

$864,452

Previous $711,000 4.92%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.81 - $18.96 $37,327 - $44,764	-2,361 Reduced 5.4%	41,401 $746,000
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $21,074 - $28,692	1,649 Added 3.92%	43,762 $711,000
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $256,986 - $347,546	24,085 Added 133.6%	42,113 $594,000
Q4 2023 Jan 26, 2024	BUY	$8.12 - $10.63 $146,387 - $191,637	18,028 New	18,028 $188,000
Q1 2021 May 12, 2021	BUY	$10.34 - $12.81 $121,443 - $150,453	11,745 New	11,745 $136,000
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $288,323 - $370,305	-18,506 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$14.59 - $23.84 $57,353 - $93,715	3,931 Added 26.97%	18,506 $285,000
Q3 2018 Nov 15, 2018	SELL	$21.06 - $25.65 $1,726 - $2,103	-82 Reduced 0.56%	14,575 $314,000
Q2 2018 Aug 15, 2018	BUY	$16.77 - $24.71 $49,823 - $73,413	2,971 Added 25.42%	14,657 $356,000
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $21,633 - $28,624	-1,297 Reduced 9.99%	11,686 $200,000
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $145,799 - $247,975	12,983	12,983 $246,000

Others Institutions Holding TEVA

# of Institutions

626

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Teva Pharmaceutical Industries LTD Transaction History